Holen Sie sich die Stockscreener-App
8.9166
1.06%
-0.0834
Organon Co Aktie (OGN) Neueste Nachrichten
Organon (OGN) Stock Sinks As Market Gains: What You Should Know - sharewise.com
Organon & Co. (OGN) Stock Analysis: Navigating a Challenging Landscape with Strategic Potential - DirectorsTalk Interviews
Valuation Update: Is Organon Co subject to activist investor interest2025 Pullback Review & Fast Entry Momentum Alerts - baoquankhu1.vn
543,711 Shares in Organon & Co. $OGN Purchased by Sector Gamma AS - MarketBeat
Organon & Co (OGN) Is Quietly Moving – Is This ‘Boring’ Stock Actually a Game-Changer for Your - AD HOC NEWS
Sun Pharma Bid Puts Organon Valuation And Growth Prospects In Focus - Sahm
(OGN) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Acquisition Speculation and Regulatory Approval Drive Organon Shares - AD HOC NEWS
Organon Lures Sun Pharma With Low Valuation & Global Reach—What’s Next? - Smartkarma
Organon gains on report of Sun Pharmaceutical interest - MSN
Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report - AOL.com
Sun Pharma again on the prowl in the US market for acquisitions - Fortune India
Sun Pharma Weighs Potential $10 Billion Bid for Organon; Shares See Volatility - Whalesbook
Sun Pharma is said to mull bid for women’s wellness firm Organon - BusinessLine
India’s biggest pharma firm said to mull bid for New York-listed Organon - MSN
India’s Biggest Pharma Firm Said to Mull Bid for New York-Listed Organon - Bloomberg
Organon (OGN) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Organon acquisition buzz brings Sun Pharma deal strategy back - MSN
Sun Pharma Receives Buy Rating with ₹2,100 Target Price Amid Organon Acquisition Plans - scanx.trade
Massachusetts Financial Services Co. MA Has $101.48 Million Stake in Organon & Co. $OGN - MarketBeat
Barclays Initiates Organon & Co(OGN.US) With Sell Rating, Announces Target Price $7.5 - 富途牛牛
Why Sun Pharma’s hefty bid for Organon has divided investors | Company Business News - Mint
Organon & Co. (NYSE:OGN) Trading Up 8.8%What's Next? - MarketBeat
Why Are Organon (OGN) Shares Soaring Today - Finviz
Organon Stock Surges After FDA Nod for Nexplanon Expansion - StocksToTrade
Organon Secures FDA Approval Extending NEXPLANON Use to Five Years - Yahoo Finance
Sun Pharmaceutical Makes Non-Binding Offer to Acquire Organon for $10B-$14B - Intellectia AI
Aug Breakouts: Is 60 Degrees Pharmaceuticals Inc. Equity Warrant attractive at current valuationMarket Risk Analysis & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Sun Pharmaceutical Evaluates Organon Acquisition to Scale US Business - Chemical Industry Digest
BRIEF—Sun Pharma clarifies $10 billion Organon acquisition report - The Pharma Letter
Organon & Co. (OGN) Stock Analysis: Evaluating the 6.82% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Sun Pharma looks to rise in US with $10 billion Organon buy - The Economic Times
Sun Pharma places non-binding offer for US-based Organon in its boldest global bet ever - The Economic Times
Organon announces U.S. FDA approved sNDA for Nexplanon - TipRanks
FDA expands use of Organon’s contraception implant up to 5 years - Medical Device Network
Sun Pharma says talk of $10bn Organon bid is 'speculative' - pharmaphorum
Sun Pharma terms $10 billion Organon acquisition reports 'speculative' - Business Standard
Sun Pharma terms $10-billion Organon buy report as 'speculative' - Moneycontrol
Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque - BioSpace
Sun Pharma tight-lipped over rumoured $10B deal for Organon - FirstWord Pharma
M&A News: India’s Sun Pharma Eyes $10B Bid for U.S.’ Organon - TipRanks
Sun Pharma clarifies $10 bn Organon acquisition report, calls it 'speculative in nature' - The Economic Times
Sun Pharmaceutical Industries Denies $10 Billion Organon Acquisition Rumors - scanx.trade
India’s Sun Pharma weighs $10 bln bid for US-listed Organon, ET reports By Investing.com - Investing.com South Africa
India’s Sun Pharma weighs $10 bln bid for US-listed Organon, ET reports - Investing.com
Sun Pharma Officially Denies $10 Billion Organon Acquisition Speculation - scanx.trade
Organon (OGN) Receives FDA Approval for Nexplanon Label Expansion to 5 Years - Intellectia AI
Organon wins FDA nod to expand use of Nexplanon birth control implant - Seeking Alpha
Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Exte - PharmiWeb.com
Birth control implant Nexplanon now approved to last 5 years in US - Stock Titan
Organon (OGN) Receives FDA Approval to Extend NEXPLANON Use to 5 Years - Intellectia AI
Organon (OGN) Receives FDA Approval for NEXPLANON Extended Use Up to 5 Years - Intellectia AI
Performance Recap: Whats the beta of Organon Co stockJuly 2025 Earnings & Detailed Earnings Play Alerts - baoquankhu1.vn
Global Organon employees on leading Pride Network and building inclusive workplaces - attitude.co.uk
Earnings Recap: Whats the beta of Organon Co stockLong Setup & Daily Chart Pattern Signals - baoquankhu1.vn
OGNORGANON & CO Latest Stock News & Market Updates - Stock Titan
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):